Wesbanco Bank Inc Biogen Inc. Transaction History

Wesbanco Bank Inc

$2.64 Billion
Q2 2024

A detailed history of Wesbanco Bank Inc transactions in Biogen Inc. stock. As of the latest transaction made, Wesbanco Bank Inc holds 1,458 shares of BIIB stock, worth $330,091. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,458

Previous 1,488 2.02%

Holding current value

$330,091

Previous $320,000 5.31%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$190.52 - $236.72 $5,715 - $7,101	-30 Reduced 2.02%	1,458 $337,000
Q1 2024 Apr 23, 2024	BUY	$212.02 - $267.71 $315,485 - $398,352	1,488 New	1,488 $320,000
Q4 2022 Jan 18, 2023	BUY	$252.44 - $306.72 $375,630 - $456,399	1,488 New	1,488 $412,000
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $3,367 - $5,391	13 Added 0.3%	4,288 $1.49 Million
Q2 2020 Jul 14, 2020	SELL	$258.66 - $342.55 $51,732 - $68,510	-200 Reduced 4.47%	4,275 $1.14 Million

Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $25,875 - $29,021	-119 Reduced 2.59%	4,475 $1.04 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $243,411 - $268,309	1,110 Added 31.86%	4,594 $1.07 Million
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $406,114 - $635,211	1,874 Added 116.4%	3,484 $823,000
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $26,457 - $33,511	-95 Reduced 5.57%	1,610 $484,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $41,091 - $53,736	140 Added 8.95%	1,705 $602,000
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $7,725 - $9,207	-30 Reduced 1.88%	1,565 $454,000
Q1 2018 May 18, 2018	BUY	$260.13 - $367.91 $41,620 - $58,865	160 Added 11.15%	1,595 $437,000
Q4 2017 Feb 01, 2018	SELL	$307.64 - $344.58 $10,459 - $11,715	-34 Reduced 2.31%	1,435 $457,000
Q3 2017 Nov 02, 2017	SELL	$281.15 - $329.69 $14,057 - $16,484	-50 Reduced 3.29%	1,469 $460,000
Q2 2017 Aug 08, 2017	BUY	N/A	1,519	1,519 $413,000

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Biogen Inc. Transaction History